- Home
- TRN vs BEAM Comparison
TRN vs BEAM Comparison
Compare TRN & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRN
- BEAM
- Stock Information
- Founded
- TRN 1933
- BEAM 2017
- Country
- TRN United States
- BEAM United States
- Employees
- TRN N/A
- BEAM N/A
- Industry
- TRN Railroads
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRN Industrials
- BEAM Health Care
- Exchange
- TRN Nasdaq
- BEAM Nasdaq
- Market Cap
- TRN 2.6B
- BEAM 2.0B
- IPO Year
- TRN N/A
- BEAM 2020
- Fundamental
- Price
- TRN $31.05
- BEAM $23.31
- Analyst Decision
- TRN Buy
- BEAM Buy
- Analyst Count
- TRN 3
- BEAM 9
- Target Price
- TRN $31.00
- BEAM $44.11
- AVG Volume (30 Days)
- TRN 457.0K
- BEAM 645.9K
- Earning Date
- TRN 10-31-2024
- BEAM 08-06-2024
- Dividend Yield
- TRN 3.61%
- BEAM N/A
- EPS Growth
- TRN 109.93
- BEAM N/A
- EPS
- TRN 1.95
- BEAM N/A
- Revenue
- TRN $3,270,200,000.00
- BEAM $352,567,000.00
- Revenue This Year
- TRN $5.25
- BEAM N/A
- Revenue Next Year
- TRN $1.15
- BEAM $3.59
- P/E Ratio
- TRN $15.90
- BEAM N/A
- Revenue Growth
- TRN 33.37
- BEAM 339.83
- 52 Week Low
- TRN $20.04
- BEAM $16.95
- 52 Week High
- TRN $37.04
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- TRN 40.37
- BEAM 39.61
- Support Level
- TRN $32.14
- BEAM $23.85
- Resistance Level
- TRN $33.20
- BEAM $27.71
- Average True Range (ATR)
- TRN 0.73
- BEAM 1.41
- MACD
- TRN -0.15
- BEAM -0.20
- Stochastic Oscillator
- TRN 10.34
- BEAM 5.17
About TRN Trinity Industries Inc.
Trinity Industries Inc. sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in three main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in the industries of agriculture, construction, consumer products, energy, and chemicals.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.